David Grevent

David Grevent

Auto-generated profile, based on publicly available information

David Grevent

Paediatric Radiology Department, Assistance Publique–Hopitaux de Paris, Hôpital Necker Enfants Malades, Université de Paris, Paris, France

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2017 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
JRJean-Antoine Ribeil
Jean-Antoine Ribeil
SHSalima Hacein-Bey-Abina
Salima Hacein-Bey-Abina
EPEmmanuel Payen
Emmanuel Payen
AMAlessandra Magnani
Alessandra Magnani
MSMichaela Semeraro
Michaela Semeraro
MCMarina Cavazzana
Marina Cavazzana
Sickle cell disease results from a homozygous missense mutation in the β-globin gene that causes polymerization of hemoglobin S. Gene therapy for patients with this disorder is complicated by the complex cellular abnormalities and challenges in achieving effective, persistent inhibition of polymerization of hemoglobin S. We describe our first patient treated with lentiviral vector–mediated addition of an antisickling β-globin gene into autologous hematopoietic stem cells. Adverse events were consistent with busulfan conditioning. Fifteen months after treatment, the level of therapeutic antisickling β-globin remained high (approximately 50% of β-like–globin chains) without recurrence of sickle crises and with correction of the biologic hallmarks of the disease. (Funded by Bluebird Bio and others; HGB-205 ClinicalTrials.gov number, NCT02151526.)

1 November 2016 in Radiology
Verified
Journal Article
Closed access
VDVolodia Dangouloff-Ros
Volodia Dangouloff-Ros
CDChristophe Deroulers
Christophe Deroulers
FFFrantz Foissac
Frantz Foissac
MBMathilde Badoual
Mathilde Badoual
ESEimad Shotar
Eimad Shotar
NBNathalie Boddaert
Nathalie Boddaert
Arterial spin labeling enabled us to distinguish low-grade tumors from higher-grade tumors in posterior fossa, thalamic, and hemispheric tumors in a large cohort of patients with pediatric brain tumors. PurposeTo compare arterial spin labeling (ASL) data between low- and high-grade brain tumors in children to establish a cutoff to distinguish low- from high-grade neoplasms and to assess potential correlations between cerebral blood flow (CBF) and quantitative histologic microvascular data.Materials and MethodsApproval was obtained from the regional review board. ASL data obtained in 129 children between 2011 and 2015 were retrospectively analyzed. CBF and relative CBF in the most perfused area of each neoplasm and contrast enhancement were quantified with a semiquantitative ratio. The correlation between CBF and microvascular density was analyzed in specimens stained with anti-CD34. Results were controlled in two validation cohorts with 1.5- and 3.0-T magnetic resonance (MR) imaging.ResultsMean CBF was significantly higher for high-grade than for low-grade hemispheric (116 mL/min/100 g [interquartile range {IQR}, 73–131 mL/min/100 g] vs 29 mL/min/100 g [IQR, 23–35 29 mL/min/100 g], P < .001), thalamic (8...

23 October 2010 in Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
ALA S Lebre
A S Lebre
MRM Rio
M Rio
LDL Faivre D'Arcier
L Faivre D'Arcier
DVD Vernerey
D Vernerey
PLP Landrieu
P Landrieu
NBN Boddaert
N Boddaert
Objective: To identify a consistent pattern of brain MRI imaging in primary complex I deficiency. Complex I deficiency, a major cause of respiratory chain dysfunction, accounts for various clinical presentations, including Leigh syndrome. Human complex I comprises seven core subunits encoded by mitochondrial DNA (mtDNA) and 38 core subunits encoded by nuclear DNA (nDNA). Moreover, its assembly requires six known and many unknown assembly factors. To date, no correlation between genotypes and brain MRI phenotypes has been found in complex I deficiencies. Design and subjects: The brain MRIs of 30 patients carrying known mutation(s) in genes involved in complex I were retrospectively collected and compared with the brain MRIs of 11 patients carrying known mutations in genes involved in the pyruvate dehydrogenase (PDH) complex as well as 10 patients with MT-TL1 mutations. Results: All complex I deficient patients showed bilateral brainstem lesions (30/30) and 77% (23/30) showed anomalies of the putamen. Supratentorial stroke-like lesions were only observed in complex I deficient patients carrying mtDNA mutations (8/19) and necrotising leucoencephalopathy in patients with nDNA mutations (4/5). Conversely, the isolated stroke-like images observed in patients with MT-TL1 mutations, or the corpus callosum malformations observed in PDH deficient patients, were never observed in complex I deficient patients. Conclusion: A common pattern of brain MRI imaging was identified with abnormal signal intensities in brainstem and subtentorial nuclei with lactate peak as a clue of complex I deficiency. Combining clinico-biochemical data with brain imaging may therefore help orient genetic studies in complex I deficiency.

1 August 2017 in Stroke
Verified
Journal Article
Open access
PDF file
LTLaurence Tabone
Laurence Tabone
NMNicolas Mediamolle
Nicolas Mediamolle
CBCeline Bellesme
Celine Bellesme
FLFabrice Lesage
Fabrice Lesage
DGDavid Grevent
David Grevent
MKManoelle Kossorotoff
Manoelle Kossorotoff
Background and Purpose—To evaluate hyperacute management of pediatric arterial ischemic stroke, setting up dedicated management pathways is the first recommended step to prove the feasibility and safety of such treatments. A regional pediatric stroke alert protocol including 2 centers in the Paris-Ile-de-France area, France, was established. Methods—Consecutive pediatric patients (28 days–18 years) with confirmed arterial ischemic stroke who had acute recanalization treatment (intravenous r-tPA [recombinant tissue-type plasminogen activator], endovascular procedure, or both) according to the regional pediatric stroke alert were retrospectively reviewed during a 40-month period. Results—Thirteen children, aged 3.7 to 16.6 years, had recanalization treatment. Median time from onset to magnetic resonance imaging was 165 minutes (150–300); 9 out of 13 had large-vessel occlusion. Intravenous r-tPA was used in 11 out of 13 patients, with median time from onset to treatment of 240 minutes (178–270). Endovascular procedure was performed in patients time-out for intravenous r-tPA (n=2) or after intravenous r-tPA inefficiency (n=2). No intracranial or peripheral bleeding was reported. One patient died of malignant stroke; outcome was favorable in 11 out of 12 survivors (modified Rankin Scale score 0–2). Conclusions—Hyperacute recanalization treatment in pediatric stroke, relying on common protocols and adult/pediatric ward collaboration, is feasible. Larger systematic case collection is encouraged.

1 December 2014 in Epilepsy Research
Verified
Journal Article
Closed access
TBThomas Blauwblomme
Thomas Blauwblomme
NBNathalie Boddaert
Nathalie Boddaert
NCNicole Chémaly
Nicole Chémaly
CCCatherine Chiron
Catherine Chiron
MPMélanie Pages
Mélanie Pages
RNRima Nabbout
Rima Nabbout

10 May 2013 in Developmental Medicine & Child Neurology
Verified
Journal Article
Closed access
CGCyril Gitiaux
Cyril Gitiaux
PKPauline Krug
Pauline Krug
DGDavid Grevent
David Grevent
MKManoelle Kossorotoff
Manoelle Kossorotoff
SPSarah Poncet
Sarah Poncet
IDIsabelle Desguerre
Isabelle Desguerre